Mohammad N Uddin
Overview
Explore the profile of Mohammad N Uddin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
837
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehmood Y, Shahid H, Nazir R, Uddin M, Nur-E-Alam M, Bourhia M, et al.
BMC Pharmacol Toxicol
. 2025 Feb;
26(1):32.
PMID: 39953569
The aim of this study was to develop a ciclopirox (CXP) topical nano spray using nanotechnology to enhance drug bioavailability and skin absorption. A precipitation method was employed to incorporate...
2.
Pantho A, Singh M, Afroze S, Kelso K, Ehrig J, Vora N, et al.
Cells
. 2024 Nov;
13(21.
PMID: 39513907
Preeclampsia (preE) is a hypertensive disorder in pregnancies. It is the third leading cause of mortality among pregnant women and fetuses worldwide, and there is much we have yet to...
3.
Moon S, Zhao F, Uddin M, Tucker C, Karmaus P, Fessler M
JCI Insight
. 2024 Nov;
9(24).
PMID: 39499901
T cell receptor (TCR) engagement triggers T cell responses, yet how TCR-mediated activation is regulated at the plasma membrane remains unclear. Here, we report that deleting the membrane scaffolding protein...
4.
Pasupuleti D, Bagwe P, Ferguson A, Uddin M, DSouza M, Zughaier S
Vaccines (Basel)
. 2024 Sep;
12(9).
PMID: 39340079
Inducing T lymphocyte (T-cell) activation and proliferation with specificity against a pathogen is crucial in vaccine formulation. Assessing vaccine candidates' ability to induce T-cell proliferation helps optimize formulation for its...
5.
Pantho A, Mohamed S, Govande J, Rane R, Vora N, Kelso K, et al.
Cells
. 2024 Sep;
13(18.
PMID: 39329718
Methods: Human CTB cells were treated with 100, 150, 200, 300, or 400 mg/dL glucose for 48 h. Some cells were pretreated with pravastatin (1 µg/mL), while others were cotreated...
6.
Sultan M, Parveen S, Uddin M, Jubeen F, Kazi M
Acta Pharm
. 2024 Sep;
74(3):525-537.
PMID: 39279522
Polyurethane/hydroxyapatite (PU/HA) composites are well-known for various biomedical applications. This study reports a chemical approach to improve the interaction between HA and PU matrix. HA was surface-modified with 1,6-hexamethylene diisocyanate...
7.
Shah S, Patel P, Ferguson A, Bagwe P, Kale A, Adediran E, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066358
Over the years, research regarding the Zika virus has been steadily increasing. Early immunization for ZIKV is a priority for preventing complications such as microencephaly and Guillain-Barré syndrome (GBS). Unlike...
8.
Shah S, Patel P, Bagwe P, Kale A, Ferguson A, Adediran E, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932158
Humans continue to be at risk from the Zika virus. Although there have been significant research advancements regarding Zika, the absence of a vaccine or approved treatment poses further challenges...
9.
Foo A, Edin M, Lin W, Lih F, Gabel S, Uddin M, et al.
Biochemistry
. 2024 Jun;
63(14):1730-1737.
PMID: 38915291
The cockroach allergen Bla g 1 encloses an exceptionally large hydrophobic cavity, which allows it to bind and deliver unsaturated fatty acid ligands. Bla g 1-mediated delivery of naturally occurring...
10.
Moon S, Zhao F, Uddin M, Tucker C, Karmaus P, Fessler M
bioRxiv
. 2024 May;
PMID: 38746431
T cell receptor (TCR) engagement triggers T cell responses, yet how TCR-mediated activation is regulated at the plasma membrane remains unclear. Here, we report that deleting the membrane scaffolding protein...